BRIEF published on 11/13/2025 at 07:35, 1 month 6 days ago Dermapharm maintient sa stabilité malgré les ajustements de son portefeuille Croissance Et Bénéfices Dermapharm Restructuration Du Portefeuille Résultats Financiers De 2025 Médicaments De Marque
BRIEF published on 11/13/2025 at 07:35, 1 month 6 days ago Dermapharm Maintains Stability Amid Portfolio Adjustments Growth And Earnings Branded Pharmaceuticals Dermapharm 2025 Financial Results Portfolio Restructuring
PRESS RELEASE published on 11/13/2025 at 07:30, 1 month 6 days ago Stable earnings despite portfolio adjustment - 2025 guidance confirmed, strong growth in branded pharmaceuticals Dermapharm Holding SE reports stable earnings despite portfolio adjustments in Q3 2025, confirms 2025 guidance and strong growth in branded pharmaceuticals Pharmaceuticals Growth Earnings Dermapharm Holding SE Portfolio Adjustment
BRIEF published on 08/26/2025 at 07:35, 3 months 24 days ago Dermapharm annonce une activité stable au premier semestre 2025 et une croissance de l'EBITDA au deuxième trimestre Résultats Financiers Croissance De L'EBITDA Stabilité Des Revenus Produits Pharmaceutiques De Marque Performances De Dermapharm
BRIEF published on 08/26/2025 at 07:35, 3 months 24 days ago Dermapharm Reports Stable Business in H1 2025 and Q2 EBITDA Growth Financial Results EBITDA Growth Revenue Stability Branded Pharmaceuticals Dermapharm Performance
PRESS RELEASE published on 08/26/2025 at 07:30, 3 months 24 days ago Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter Dermapharm confirms stable business development in H1 2025 with EBITDA growth in Q2. Full-year guidance for 2025 reiterated. Branded pharmaceuticals main growth driver Revenue Pharmaceuticals EBITDA Growth Dermapharm H1 2025
BRIEF published on 08/12/2025 at 07:35, 4 months 7 days ago Dermapharm Holding SE poursuit sa croissance au deuxième trimestre 2025 Prévisions De Revenus Croissance De L'EBITDA Produits Pharmaceutiques De Marque Dermapharm Performances Du Deuxième Trimestre 2025
BRIEF published on 08/12/2025 at 07:35, 4 months 7 days ago Dermapharm Holding SE Continues Growth in Q2 2025 Revenue Forecast EBITDA Growth Branded Pharmaceuticals Dermapharm Q2 2025 Performance
PRESS RELEASE published on 08/12/2025 at 07:30, 4 months 7 days ago Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE reports Q2 2025 results in line with expectations. Confirms full-year guidance of EUR 1,160–1,200 million revenue and EUR 322–332 million EBITDA Pharmaceuticals EBITDA Growth Dermapharm Holding SE Full-year Guidance Q2 2025 Results
BRIEF published on 06/26/2025 at 17:48, 5 months 22 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
Published on 12/19/2025 at 14:40, 2 hours 25 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 3 hours 35 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 3 hours 35 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 3 hours 35 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 13:05, 4 hours ago Roxmore Resources Begins Trading on the OTCQX Best Market in the United States
Published on 12/19/2025 at 16:51, 14 minutes ago EQS-Adhoc: JENOPTIK AG: Daniela Mattheus becomes new Chairwoman of the Supervisory Board of JENOPTIK AG
Published on 12/19/2025 at 16:30, 35 minutes ago The Platform Group acquires fashion platform 43einhalb
Published on 12/19/2025 at 14:54, 2 hours 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/19/2025 at 08:30, 8 hours 35 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 8 hours 35 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 10 hours 5 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 10 hours 5 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 22 hours 35 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
